Shares of Merus (NASDAQ:MRUS – Get Rating) saw an uptick in trading volume on Friday . 1,205,280 shares were traded during trading, an increase of 316% from the previous session’s volume of 290,048 shares.The stock last traded at $22.24 and had previously closed at $19.52. Analyst Ratings Changes Several research firms have issued reports on […]
Needham & Company LLC reaffirmed their buy rating on shares of Merus (NASDAQ:MRUS – Get Rating) in a research note released on Thursday morning, Benzinga reports. The firm currently has a $33.00 target price on the biotechnology company’s stock. Several other brokerages have also recently issued reports on MRUS. HC Wainwright boosted their price target […]
Merus (NASDAQ:MRUS – Get Rating) had its target price raised by Citigroup from $30.00 to $38.00 in a report published on Wednesday morning, The Fly reports. Citigroup currently has a buy rating on the biotechnology company’s stock. A number of other research analysts have also weighed in on the company. HC Wainwright upped their price […]
Ceapro (OTCMKTS:CRPOF – Get Rating) and Merus (NASDAQ:MRUS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends. Analyst Recommendations This is a summary of recent ratings and price […]
Merus (NASDAQ:MRUS – Get Rating) had its price objective lifted by equities research analysts at Citigroup from $30.00 to $38.00 in a research note issued on Wednesday, The Fly reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Citigroup’s target price would indicate a potential upside of 107.31% from the stock’s […]